Nephros Inc (NEPH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nephros Inc (NEPH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6435
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended to be used to filter water and bicarbonate concentrate used in hemodialysis devices to assist in providing hemodialysis quality water or bicarbonate concentrates. The company offers infection control filters such as ice machine solutions, shower solutions and sink products. Its products are used in conjunction with other water treatment equipment. Nephros dialysis products are used in removal of biological contaminants. The company markets its products through a network of distributors in the US. Nephros is headquartered in South Orange, New Jersey, the US.

Nephros Inc (NEPH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nephros Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nephros Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Nephros Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Nephros Inc, Medical Equipment, Deal Details 11
Partnerships 11
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters into Agreement with CS Medical 12
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 13
Equity Offering 14
Nephros Raises USD2.9 Million in Private Placement of Shares 14
Nephros Raises USD1.2 Million in Private Placement of Shares and Warrants 15
Nephros Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Nephros to Raise USD10 Million in Private Placement of Shares 18
Nephros Raises USD1.2 Million in Private Placement of Shares 20
Nephros Raises USD3 Million in Rights Offering 21
Nephros Completes Rights Offering Of Shares For US$2 Million 22
Nephros Completes Rights Offering Of Shares For US$3 Million 23
Nephros Inc – Key Competitors 24
Nephros Inc – Key Employees 25
Nephros Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 08, 2018: Nephros reports second quarter 2018 financial results 27
Jul 09, 2018: Nephros Announces Preliminary Financial Results for Second Quarter 2018 28
May 09, 2018: Nephros Reports First Quarter 2018 Financial Results 29
Apr 16, 2018: Nephros Announces Preliminary Financial Results For First Quarter 2018 30
Feb 26, 2018: Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update 31
Jan 04, 2018: Nephros Announces Preliminary Financial Results for Fourth Quarter 2017 33
Nov 09, 2017: Nephros Reports Third Quarter 2017 Financial Results 34
Aug 08, 2017: Nephros Reports Second Quarter Financial Results and Receives NJEDA Approval for Approximately $1.5 million in Funding from Sale of Tax Credits 35
May 09, 2017: Nephros Reports 2017 First Quarter Financial Results and Provides Corporate Update 36
Mar 20, 2017: Nephros Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Corporate Update 37
Jan 24, 2017: Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance 39
Corporate Communications 41
Aug 13, 2018: Nephros appoints Oliver Spandow to its board of directors 41
Nov 06, 2017: Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits 42
Feb 14, 2017: Nephros Announces Appointment of Andrew Astor as Chief Financial Officer 43
Product News 44
Dec 04, 2017: Nephros CFO to Present at the 10th Annual LD Micro Main Event 44
Other Significant Developments 45
Oct 16, 2017: Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue 45
Sep 27, 2017: Nephros Shareholder Letter 46
Jul 10, 2017: Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Nephros Inc, Medical Equipment, Key Facts, 2017 2
Nephros Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nephros Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nephros Inc, Deals By Market, 2012 to YTD 2018 9
Nephros Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Nephros Extends Licensing Agreement With Bellco For Mid-Dilution Dialysis Products 11
Nephros Enters into Agreement with CS Medical 12
Nephros And Mar Cor Purification Enter Into Distribution Agreement For Dialysis Ultrafilters 13
Nephros Raises USD2.9 Million in Private Placement of Shares 14
Nephros Raises USD1.2 Million in Private Placement of Shares and Warrants 15
Nephros Raises USD0.2 Million in Private Placement of Shares upon Exercise of Warrants 16
Nephros to Raise USD10 Million in Private Placement of Shares 18
Nephros Raises USD1.2 Million in Private Placement of Shares 20
Nephros Raises USD3 Million in Rights Offering 21
Nephros Completes Rights Offering Of Shares For US$2 Million 22
Nephros Completes Rights Offering Of Shares For US$3 Million 23
Nephros Inc, Key Competitors 24
Nephros Inc, Key Employees 25

List of Figures
Nephros Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nephros Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Nephros Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Nephros Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Nephros Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Nephros Inc (NEPH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Annaly Capital Management Inc:企業の戦略・SWOT・財務情報
    Annaly Capital Management Inc - Strategy, SWOT and Corporate Finance Report Summary Annaly Capital Management Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Guided Therapeutics Inc (GTHP):企業の財務・戦略的SWOT分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Powszechny Zaklad Ubezpieczen Group:企業の戦略・SWOT・財務情報
    Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report Summary Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • A. Menarini Industrie Farmaceutiche Riunite Srl:企業の戦略的SWOT分析
    A. Menarini Industrie Farmaceutiche Riunite Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • SLM Corp:企業の戦略・SWOT・財務情報
    SLM Corp - Strategy, SWOT and Corporate Finance Report Summary SLM Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Dalian Port (PDA) Co Ltd (2880):石油・ガス:M&Aディール及び事業提携情報
    Summary Dalian Port (PDA) Co Ltd (Dalian), a subsidiary of Dalian Port Corp Ltd is an oil and gas company that offers port and logistic services. The company offers services such as passenger and roll-on, roll-off terminal, bulk grain terminal, and related logistics services. It also provides oil an …
  • W.W. Grainger Inc (GWW):企業の財務・戦略的SWOT分析
    W.W. Grainger Inc (GWW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Medison Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Medison Pharma Ltd (Medison) is a drug company that develops and manufactures medical products. The company's oncology products include vectibix, myocet, aranesp, symphony and coloprint. Its neurology products are avonex, tysabri, fampyra, provigil, stryker, dysport and firdapse. Medison off …
  • AviChina Industry & Technology Co., Ltd. (2357):企業の財務・戦略的SWOT分析
    AviChina Industry & Technology Co., Ltd. (2357) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • AlloSource:企業の戦略的SWOT分析
    AlloSource - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Bellway Plc (BWY):企業の財務・戦略的SWOT分析
    Bellway Plc (BWY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析
    Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Polski Koncern Naftowy Orlen SA (PKN):石油・ガス:M&Aディール及び事業提携情報
    Summary Polski Koncern Naftowy Orlen SA (PKN Orlen) is an integrated oil and gas company. It explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. Its product portf …
  • Fomento de Construcciones y Contratas S.A.:企業の戦略・SWOT・財務情報
    Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report Summary Fomento de Construcciones y Contratas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Qatar Fuel (WOQOD) Q.S.C. (QFLS):企業の財務・戦略的SWOT分析
    Qatar Fuel (WOQOD) Q.S.C. (QFLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cree Inc (CREE)-エネルギー分野:企業M&A・提携分析
    Summary Cree, Inc. (Cree) is a lighting class LED's, LED lighting, and semiconductor solutions provider, that develops and manufactures semiconductor materials and devices principally based on silicon carbide (SiC), gallium nitride (GaN), and other related compounds. Cree’s product portfolio include …
  • Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Coresa SA:企業の戦略・SWOT・財務情報
    Coresa SA - Strategy, SWOT and Corporate Finance Report Summary Coresa SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Pier 1 Imports, Inc.:企業の戦略・SWOT・財務情報
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆